Prophylaxis and Treatment of Acute Graft-Versus-Host Disease
- 31 January 2006
- journal article
- review article
- Published by Elsevier BV in Seminars in Hematology
- Vol. 43 (1), 32-41
- https://doi.org/10.1053/j.seminhematol.2005.09.007
Abstract
No abstract availableThis publication has 90 references indexed in Scilit:
- Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trialBlood, 2004
- A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host diseaseTransplantation and Cellular Therapy, 2000
- Feasibility and response to budesonide as topical corticosteroid therapy for acute intestinal GVHDBone Marrow Transplantation, 1999
- Bone Marrow NK1.1− and NK1.1+ T Cells Reciprocally Regulate Acute Graft versus Host DiseaseThe Journal of Experimental Medicine, 1999
- Interaction of antigenic peptides with MHC and TCR moleculesClinical Immunology and Immunopathology, 1995
- Cytotoxic Lymphocytes: Two ways to kill target cellsCurrent Biology, 1994
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaThe New England Journal of Medicine, 1986
- Graft-versus-Host Disease and Survival in Patients with Aplastic Anemia Treated by Marrow Grafts from HLA-Identical SiblingsThe New England Journal of Medicine, 1983
- Rapid increase of phosphoribosyl pyrophosphate concentration after mitogenic stimulation of lymphocytesFEBS Letters, 1975
- Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.The Journal of Antibiotics, 1975